We found a significant downregulation of SREBF1 in adenocarcinoma (ADC) and although statistically nonsignificant, also a downregulation in squamous cell carcinoma (SQCC) (Figure 8A, Supplementary Figure S4). Here, SREBF1 is linked to squamous cell carcinoma.